Your browser doesn't support javascript.
loading
Comprehensive study for BRCA1 and BRCA2 entire coding regions in breast cancer
Algebaly, A. S; Suliman, R. S; Al-Qahtani, W. S.
Afiliação
  • Algebaly, A. S; Princess Nourah Bint Abdulrahman University. College of Science. Biology Department. Riyadh. Saudi Arabia
  • Suliman, R. S; Princess Nourah Bint Abdulrahman University. College of Science. Biology Department. Riyadh. Saudi Arabia
  • Al-Qahtani, W. S; Princess Nourah Bint Abdulrahman University. College of Science. Biology Department. Riyadh. Saudi Arabia
Clin. transl. oncol. (Print) ; 23(1): 74-81, ene. 2021. graf
Artigo em Inglês | IBECS | ID: ibc-220452
Biblioteca responsável: ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Background About 5–10% of incidences of breast cancers have been reported as a result of germline mutations of BRCA genes. However, the mutational spectrum of BRCA1 and BRCA2 genes among breast cancer Saudi women patients is inadequate at present. Therefore, the present study aimed to report the specific germinal mutation of BRCA1 and BRCA2 in the entire coding regions, to investigate the prevalence rate of BRCA1 & BRCA2 mutations among Saudi women and the effect of these mutations, both benign and malignant tumors. Methodology A total of 270 tissue samples of benign and malignant breast tumors were collected from Saudi women patients, Riyadh, Saudi Arabia. Examination of BRCA1 and BRCA2 germline mutations was performed using heteroduplex DNA analysis (HDA) or single-stranded conformation analysis (SSCA). 177 breast cancer women with malignant tumors and 93 with benign tumors were enrolled in the study. A total of 62 out of 177 breast cancer patients carried a BRCA1 or BRCA2 mutation (54 BRCA1 and 8 BRCA2). The analysis was done using the Sanger sequence assay. Results Point and frameshift mutations through the entire coding area of the two genes indicated that all the mutations were germline alterations and of early-onset breast cancers. The mean ages of diagnosed breast cancer women for BRCA1 and BRCA2 mutation carriers were 36.3 (± 3.5) and 37.9 (± 3.7) years, whereas that of benign control was 35(± 2.5) years. Conclusion Point and frameshift mutations across the entire coding region of BRCA1 and BRCA2 are responsible for many breast cancers cases (AU)
Assuntos

Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Neoplasias da Mama / Mutação em Linhagem Germinativa / Genes BRCA1 / Genes BRCA2 Limite: Adulto / Feminino / Humanos País/Região como assunto: Ásia Idioma: Inglês Revista: Clin. transl. oncol. (Print) Ano de publicação: 2021 Tipo de documento: Artigo Instituição/País de afiliação: Princess Nourah Bint Abdulrahman University/Saudi Arabia
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Neoplasias da Mama / Mutação em Linhagem Germinativa / Genes BRCA1 / Genes BRCA2 Limite: Adulto / Feminino / Humanos País/Região como assunto: Ásia Idioma: Inglês Revista: Clin. transl. oncol. (Print) Ano de publicação: 2021 Tipo de documento: Artigo Instituição/País de afiliação: Princess Nourah Bint Abdulrahman University/Saudi Arabia
...